Jonathan Eitan Solomon - 14 Apr 2025 Form 4/A - Amendment Insider Report for BiomX Inc. (PHGE)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Solomon
Issuer symbol
PHGE
Transactions as of
14 Apr 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
21 Apr 2025, 08:09:29 UTC
Date Of Original Report
18 Apr 2025
Previous filing
18 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock Award $0 +126,748 $0.000000 126,748 14 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - right to Buy Award $0 +380,500 $0.000000 380,500 14 Apr 2025 Common Stock 380,500 $0.5380 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of 126,748 Restricted Stock Units ("RSUs"). The RSUs are immediately vested and convert into the Issuer's shares of common stock on a one-for-one basis.
F2 The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.

Remarks:

This amendment is being filed solely to correct an administrative error in Table II, Column 5. The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A). No other changes have been made to the originally filed Form 4.